Market Newsdesk

NEW YORK, Sept. 5, 2026 /PRNewswire/ —

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the “Class Period”), of the important September 28, 2026 lead plaintiff deadline.

So what: If you purchased Park Ha securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Park Ha class action, go to https://rosenlegal.com/cases/park-ha-biological-technology-co-ltd-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 28, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose material adverse facts about Park Ha’s business, operations, and the true nature of its securities trading activity. Specifically, defendants failed to disclose that: (1) Park Ha was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) Park Ha’s public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price; (3) Park Ha’s IPO was intentionally structured with an extremely low public float to enable the manipulation scheme; and (4) as a result of the foregoing, defendants’ positive statements about Park Ha’s business, operations, and prospects were misleading and/or lacked a reasonable basis.

To join the Park Ha class action, go to https://rosenlegal.com/cases/park-ha-biological-technology-co-ltd-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/phh-byah-deadline-phh-byah-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-park-ha-biological-technology-co-ltd-securities-lawsuit-302870523.html

SOURCE THE ROSEN LAW FIRM, P. A.

NEW YORK, Sept. 5, 2026 /PRNewswire/ —

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Datavault AI Inc. (NASDAQ: DVLT) between September 4, 2024 and October 30, 2025, inclusive (the “Class Period”), of the important October 5, 2026 lead plaintiff deadline.

So what: If you purchased Datavault AI securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Datavault AI class action, go to https://rosenlegal.com/cases/datavault-ai-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 5, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants made materially false and/or misleading statements and or failed to disclose that: (1) defendants had overstated the economic value to Datavault AI of its various corporate partnerships with, inter alia, Burke, Scilex, and Nature’s Miracle; (2) Defendants had overstated the volume of trading activity on the Datavault Platform, which was in fact minimal; (3) Datavault’s undisclosed connections with Edward Withrow III, a convicted felon, when revealed, would cause Datavault AI to incur reputational harm; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times.

To join the Datavault AI class action, go to https://rosenlegal.com/cases/datavault-ai-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/dvlt-investors-have-opportunity-to-lead-datavault-ai-inc-securities-fraud-lawsuit-302870468.html

SOURCE THE ROSEN LAW FIRM, P. A.

NEW YORK, Sept. 5, 2026 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of Smartsheet Inc. (NYSE: SMAR) between June 1, 2024 and September 23, 2024, both dates inclusive (the “Class Period”), of the important October 5, 2026 lead plaintiff deadline.

So what: If you purchased Smartsheet common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Smartsheet class action, go to https://rosenlegal.com/cases/smartsheet-inc-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 5, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, on January 24, 2024, Smartsheet received an unsolicited non-public offer from a consortium of investors (the “Consortium”) to purchase its outstanding shares for $56.25 per share. In April 2024, Smartsheet’s Board of Directors approved a share repurchase program under which Smartsheet could repurchase up to $150 million of its outstanding stock. On July 8, 2024, the Consortium raised its offer to $56.50 per share, and reiterated that offer on August 21, 2024. According to the lawsuit, while these offers were on the table and unknown to the investing public, Smartsheet was repurchasing its common stock at market prices significantly below the prices offered by the Consortium. Smartsheet had an obligation to disclose that it had received a formal acquisition offer from the Consortium or abstain from purchasing Smartsheet stock from unsuspecting investors.

During the Class Period, Smartsheet’s average stock price was $46.45 per share. On Tuesday, September 24, 2024, during pre-market hours, Smartsheet disclosed the transaction with the Consortium. The merger eventually closed on January 22, 2025, with the Consortium acquiring Smartsheet for $56.50 per share.

To join the Smartsheet class action, go to https://rosenlegal.com/cases/smartsheet-inc-2026/join call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/smar-investors-have-opportunity-to-lead-smartsheet-inc-securities-fraud-lawsuit-302870367.html

SOURCE THE ROSEN LAW FIRM, P. A.

NEW YORK, Sept. 5, 2026 /PRNewswire/ —

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Wix.com Ltd. (NASDAQ: WIX) between February 19, 2025 and May 12, 2026, inclusive (the “Class Period”), of the important September 22, 2026 lead plaintiff deadline.

So what: If you purchased Wix securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Wix class action, go to https://rosenlegal.com/cases/wixcom-ltd/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 22, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) Wix had overstated the competitiveness and performance of its AI product offerings relative to those offered by other companies; (2) Wix had understated the costs associated with developing and promoting its AI product offerings; (3) accordingly, defendants overstated the commercial and financial benefits of Wix’s AI product offerings; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Wix class action, go to https://rosenlegal.com/cases/wixcom-ltd/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/wix-deadline-wix-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-wixcom-ltd-securities-fraud-lawsuit-302870464.html

SOURCE THE ROSEN LAW FIRM, P. A.

Did you buy
HIMS
securities between August 4, 2025 and July 29, 2026?

Affected HIMS Investor Summary

• Who: Hims & Hers Health, Inc. (NYSE: HIMS)
• What: Securities fraud class action lawsuit filed
• Class Period: August 4, 2025 through July 29, 2026
• Deadline to Seek Lead Plaintiff Status: November 2, 2026
• Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company’s deceptive and unlawful privacy practices
• Investor Action: Contact Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) for recovery options

RADNOR, Pa., Sept. 5, 2026 /PRNewswire/ — Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against Hims & Hers Health, Inc. (HIMS) (NYSE: HIMS) on behalf of those who purchased or acquired HIMS securities between August 4, 2025 and July 29, 2026, inclusive. The lawsuit is filed in the United States District Court for the Northern District of California and is captioned Velanki v. Hims & Hers Health, Inc., No. 26-cv-09313 (N.D. Cal.). Investors have until November 2, 2026, to file for lead plaintiff status. 

CONTACT KTMC TO DISCUSS YOUR LEGAL RIGHTS:


If you purchased or acquired HIMS securities and have lost money on your investment, please provide your information here:
https://www.ktmc.com/hims-hims-hers-inc-class-action-lawsuit?utm_campaign=hc?utm_source=PR_Newswire&utm_medium=pressrelease&utm_campaign=hims&mktm=PR 

To view the HIMS video on YouTube, click here:
https://youtu.be/zCS_-D0Ocv4

You can also contact attorney

Jonathan Naji, Esq.
 by calling (484) 270-1453 or by email at [email protected]. There is no cost or obligation to speak with an attorney.

HIMS & HERS HEALTH, INC.
 CLASS ACTION LAWSUIT – COMPLAINT ALLEGATION SUMMARY:
The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material facts about the company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) HIMS shared consumers’ health information with third-party advertising platforms; (2) HIMS charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers that they will be able to consult with a medical provider to find a treatment that is “right for them;” (3) the foregoing conduct subjected HIMS to regulatory scrutiny; (4) as a result, HIMS was reasonably likely to incur fees and penalties; and (5) as a result of the foregoing, Defendants’ positive statements about the company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Why did HIMS’s Stock Drop?
On July 29, 2026, the Federal Trade Commission (“FTC”) filed a lawsuit against HIMS accusing the company of sharing customers’ medical information with third-party advertisers. Specifically,

the FTC’s criminal complaint accuses HIMS of “deceptive and unlawful privacy practices,” including sharing sensitive details about a patient’s health with Snap and Facebook parent, Meta Platforms. On this news, HIMS’s stock price declined $4.32 per share, or 14.73%, to close at $25.00 per share on July 29, 2026.

WHAT HIMS & HERS HEALTH, INC. INVESTORS CAN DO NOW:

1. File to be lead plaintiff by November 2, 2026.
2. Contact KTMC for a free case evaluation. All representation is on a contingency fee basis, there is no cost to you.
3. Retain counsel of choice or take no action.

THE LEAD PLAINTIFF PROCESS FOR HIMS & HERS HEALTH, INC. INVESTORS:

HIMS investors may, no later than November 2, 2026, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check, LLP encourages HIMS investors to contact the firm for more information.

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP (KTMC):


Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including being recognized in Chambers & Partners USA 2026 as a Band 1 Top Firm in Securities and Class Actions, Legal 500’s Tier 1 Rankings for Securities and M&A Litigation, The National Law Journal’s Plaintiff’s Hot List and Trailblazers in Plaintiffs’ Law, BTI Consulting Group’s Honor Roll of Most Feared Law Firms, The Legal Intelligencer’s Class Action Firm of the Year, Lawdragon’s Leading Plaintiff Financial Lawyers, and Law360’s Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. KTMC has recovered over $25 billion for our clients and the classes they represent. The complaint in this matter was not filed by KTMC.

CONTACT:
Jonathan Naji, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087
[email protected] 

May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-deadline-alert-hims–hers-health-inc-hims-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-302870300.html

SOURCE Kessler Topaz Meltzer & Check, LLP

NEW YORK, Sept. 5, 2026 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”), of the important September 22, 2026 lead plaintiff deadline.

So what: If you purchased PROCEPT common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the PROCEPT class action, go to https://rosenlegal.com/cases/procept-biorobotics-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 22, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that: (1) during the Class Period, Procept had utilized an extensive discount program designed to incentivize its customers to place bulk orders in excess of procedure demand; (2) Procept’s undisclosed discount program had artificially and unsustainably inflated Procept’s reported U.S. handpiece unit sales and revenues by pulling forward sales at the expense of future periods; (3) Procept’s undisclosed discount program had caused customer handpiece orders to materially exceed underlying procedure demand throughout the Class Period and that this differential had materially grown over time; (4) Procept’s consistent surplus of U.S. handpiece unit sales relative to performed procedures had created a glut of field inventory and overstocking amongst Procept’s customer base, amounting to more than 10,000 excess units by the end of the Class Period; (5) as a result of the foregoing, defendants’ representations during the Class Period regarding Procept’s handpiece unit sales and the utilization of Procept’s field Systems were materially overstated; and (6) as a result of the foregoing, Procept was acutely exposed to material undisclosed risks of significant operational and financial harm; and as a result of the foregoing, Procept was unable to achieve its stated 2025 handpiece sales and revenue guidance and such guidance lacked a reasonably achievable factual basis. When the true details entered the market, the lawsuit claims that investors suffered damages. 

To join the PROCEPT class action, go to https://rosenlegal.com/cases/procept-biorobotics-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/prct-deadline-prct-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-procept-biorobotics-corporation-securities-fraud-lawsuit-302870470.html

SOURCE THE ROSEN LAW FIRM, P. A.

The long-awaited partnership brings Ben Affleck and the Aflac Duck together on screen for the first time in a series of advertisement spots directed by Affleck.

COLUMBUS, Ga., Sept. 5, 2026 /PRNewswire/ — Two famous names have long been blurred together in pop culture: Aflac and Affleck. Today, the coincidence gets an official title card as Aflac, the leading provider of supplemental health insurance in the U.S.¹ and Artists Equity, the artist-led studio founded by Ben Affleck, Matt Damon and Gerry Cardinale, officially unveil a new partnership to bring The Man and The Duck to the screen together for the first time.

First teased last week through graffiti-tagged billboards across Los Angeles that Affleck marked up himself, the new 360-brand campaign features Affleck and the Aflac Duck in a series of commercials that combine entertainment and education to help Affleck and consumers understand what the Aflac name stands for: Providing added financial protection for expenses health insurance doesn’t cover. 

“Few brands have the recognition, trust and cultural relevance to create a partnership like this,” said Aflac President Virgil Miller. “That’s the power of the Aflac brand. Bringing together Aflac, Ben Affleck and Artists Equity creates an opportunity to reach consumers in a memorable way while reinforcing who we are as a company and the value we provide every day. It’s a bold collaboration that elevates the strength, relevance and momentum of our brand.”

The first spot, “Green Room,” opens in a backstage green room before a shoot where the Aflac Duck and Aflac’s longtime partners, coaches Nick Saban, Deion “Coach Prime” Sanders and Dawn Staley, give Affleck an impromptu crash course on what Aflac actually does and how supplemental coverage helps Americans when they need it most.

“Americans have been making the connection between Aflac and Affleck for years. Some ideas require a leap of imagination. This one was sitting right in front of us,” said Aflac Senior Vice President and Chief Marketing Officer Garth Knutson. “We think consumers are going to love it, but more importantly, we hope it inspires millions of Americans to take a fresh look at Aflac and the ways we can help with expenses health insurance doesn’t cover.”

Driven by consumers playfully linking the Aflac and Affleck names for years, Aflac and Artists Equity decided it was time to lean into it. The outcome is a new campaign that turns the name confusion into an entertaining way to spotlight a serious topic: The financial challenges that accompany a health event and how Aflac can help provide supplemental financial protection.

“What started as a coincidental word play ended up being a true connection between an iconic brand and an iconic man. Up until this point, Affleck and Aflac have just been two ships passing in the cultural night,” said Brandon Pierce, Co-President of Advertising at Artists Equity. “We saw this as a once-in-a-lifetime opportunity to bring the low-hanging fruit to life by creating an authentic campaign that’s just downright entertaining, and will feel to audiences like, ‘Wait, how has this never existed before?’ when it hits the airwaves.”

“Green Room” will air during College GameDay ahead of the Aflac Kickoff Game, taking place this Saturday, September 5. Produced and created by Artists Equity and directed by Affleck and Co-President of Advertising at Artists Equity Brandon Pierce, “Green Room” marks the beginning of a long-term creative partnership between Artists Equity and Aflac. Through a series of campaign commercials and supporting content rolling out across linear, digital and social platforms into next year, the organizations will work together to bring greater attention to the importance of supplemental insurance for Americans nationwide.

Built on a shared desire to connect with consumers in a meaningful way, Affleck and Artists Equity immersed themselves in Aflac’s business, positioning Affleck as a strategic partner in the brand’s marketing rather than just a recognizable face. Together, Artists Equity and Aflac have reimagined the brand’s iconic campaigns for a new era, reinforcing Aflac’s position as the leading provider of supplemental insurance in the U.S.

“Audiences have long decided that most advertising is built to be skipped, so we make advertising the way a studio makes a film: Attention has to be earned, which means we need to entertain,” said Josh Jefferis, Co-President of Advertising at Artists Equity. “Aflac already has one of the most recognizable brand icons ever created. Our job was to build a story worthy of the Aflac Duck, one with a costar who could keep up with the iconic quack. The Aflac team has been incredible to work with, and this is just the beginning.”

Watch the new commercial here and see the extended story here.

ABOUT AFLAC INCORPORATED


Aflac Incorporated (NYSE: AFL), a Fortune 500 company, has helped provide financial protection and peace of mind for more than seven decades to millions of policyholders and customers through its subsidiaries in the U.S. and Japan. In the U.S., Aflac is the No. 1 provider of supplemental health insurance products.¹ In Japan, Aflac Life Insurance Japan is the leading provider of cancer and medical insurance in terms of policies in force.² The company takes pride in being there for its policyholders when they need us most, as well as being included in the World’s Most Ethical Companies by Ethisphere for 20 consecutive years (2026) and Fortune’s World’s Most Admired Companies for 25 years (2026). In addition, the company became a signatory of the Principles for Responsible Investment (PRI) in 2021. To find out how to get help with expenses health insurance doesn’t cover, get to know us at aflac.com or aflac.com/español. Investors may learn more about Aflac Incorporated and its commitment to corporate social responsibility and sustainability at investors.aflac.com under “Sustainability.”

¹ LIMRA 2025 U.S. Supplemental Health Insurance Total Market Report
² As of March 31, 2025, Aflac estimates based on company data

Media contact: Adrienne Bentley, [email protected]
Analyst and investor contact: David A. Young, 706-596-3264, 800-235-2667 or [email protected]

ABOUT ARTISTS EQUITY

Artists Equity is an independent, artist-led studio reimagining the relationship between talent, studio, brands, and distributors. Across Scripted, Unscripted, and Brand Studio divisions, the company prioritizes talent through an innovative model that allows all parties to realize the value they bring to a project. It was co-founded in November 2022 by Ben Affleck, Matt Damon, and Gerry Cardinale of RedBird Capital. Artists Equity’s latest scripted film is the Netflix global chart-topper The Rip, starring Affleck, Damon, Steven Yeun, and Teyana Taylor. Other titles include The Accountant 2, The Instigators, Unstoppable, and Air, as well as the upcoming Animals, directed by Affleck, who stars alongside Kerry Washington, Gillian Anderson, and Steven Yeun. Artists Equity’s documentaries include the acclaimed Kiss the Future, Believers: Boston Red Sox, The Merchants of Joy, and The Python Hunt. Its Brand Studio division has produced four consecutive Super Bowl campaigns for Dunkin’, and one for Stella Artois. Artists Equity has multi-year film deals with Sony Pictures for theatrical and Netflix for streaming.

WWHQ | 1932 Wynnton Road | Columbus, GA 31999

View original content to download multimedia:https://www.prnewswire.com/news-releases/affleck-and-aflac-it-was-only-a-matter-of-time-302870597.html

SOURCE Aflac